Search details
1.
Oncogenic alterations in ERBB2/HER2 represent potential therapeutic targets across tumors from diverse anatomic sites of origin.
Oncologist
; 20(1): 7-12, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25480824
2.
Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer.
Oncologist
; 20(3): 316-22, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25721120
3.
Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies.
Oncologist
; 20(5): 499-507, 2015 May.
Article
in English
| MEDLINE | ID: mdl-25882375
4.
Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations.
Breast Cancer Res Treat
; 154(1): 155-62, 2015 Nov.
Article
in English
| MEDLINE | ID: mdl-26458824
5.
TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients.
Breast Cancer Res
; 16(5): 445, 2014 Oct 09.
Article
in English
| MEDLINE | ID: mdl-25307991
6.
A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice.
Oncologist
; 19(5): 453-8, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24710307
7.
New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing.
Oncologist
; 19(3): 235-42, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-24563076
8.
Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy.
Mod Pathol
; 27(2): 271-80, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-23887298
9.
Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes.
Blood
; 120(26): 5181-4, 2012 Dec 20.
Article
in English
| MEDLINE | ID: mdl-23091298
10.
Preservation of neurocognitive function and local control of 1 to 3 brain metastases treated with surgery and carmustine wafers.
Cancer
; 119(21): 3830-8, 2013 Nov 01.
Article
in English
| MEDLINE | ID: mdl-24037801
11.
Realizing improved patient care through human-centered operating room design: a human factors methodology for observing flow disruptions in the cardiothoracic operating room.
Anesthesiology
; 119(5): 1066-77, 2013 Nov.
Article
in English
| MEDLINE | ID: mdl-23811697
12.
Real-world Evidence of Diagnostic Testing and Treatment Patterns in US Patients With Breast Cancer With Implications for Treatment Biomarkers From RNA Sequencing Data.
Clin Breast Cancer
; 21(4): e340-e361, 2021 08.
Article
in English
| MEDLINE | ID: mdl-33446413
13.
Impacts of rainforest fragmentation on the composition of ground-active vertebrate communities and their patterns of seed consumption.
PLoS One
; 13(9): e0202870, 2018.
Article
in English
| MEDLINE | ID: mdl-30208055
14.
Clinical validation of the Tempus xO assay.
Oncotarget
; 9(40): 25826-25832, 2018 May 25.
Article
in English
| MEDLINE | ID: mdl-29899824
15.
Importance of circulating tumor cells in diagnosis, prognosis, and treatment selection.
Clin Adv Hematol Oncol
; 8(12): 847-8, 2010 Dec.
Article
in English
| MEDLINE | ID: mdl-21326160
16.
Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: evaluation of concordance between genomic and transcriptional profiles.
Eur J Cancer
; 51(7): 791-9, 2015 May.
Article
in English
| MEDLINE | ID: mdl-25797355
17.
Genomic alterations in DNA repair and chromatin remodeling genes in estrogen receptor-positive metastatic breast cancer patients with exceptional responses to capecitabine.
Cancer Med
; 4(8): 1289-93, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-25871911
18.
Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site: New Routes to Targeted Therapies.
JAMA Oncol
; 1(1): 40-49, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-26182302
19.
RET fusion as a novel driver of medullary thyroid carcinoma.
J Clin Endocrinol Metab
; 100(3): 788-93, 2015 Mar.
Article
in English
| MEDLINE | ID: mdl-25546157
20.
A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer.
Oncotarget
; 6(16): 14139-52, 2015 Jun 10.
Article
in English
| MEDLINE | ID: mdl-25944621